Reports on medical device adverse events widely exceed FDA deadlines, according to a recent study published in the BMJ. Read ...
Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical ...
The U.S. Food and Drug Administration said on Friday that supply interruptions of hemodialysis bloodlines, a key component in ...
Proving your product to be safe and effective while also getting buy-in from the healthcare ecosystem are only some of the ...
2d
Medical Device Network on MSNFDA approves early feasibility study of Valcare’s transcatheter deviceThe US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption application, allowing it to begin an early feasibility study of its transcatheter ...
The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among the hurdles ...
Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...
Last week, Lifeward said full-year revenue rose to $25.7 million from $13.9 million. It said ReWalk Personal Exoskeleton sales increased by 130% in 2024, fueled by recently established Medicare ...
Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results